EMA Greenlights Four New Therapies Including Deqsiga for Immune Disorders 1 year ago JohnIn Breaking NewsLeaders
Sanofi and Teva Unveil Strong Phase 2b Data for Duvakitug, Offering New Hope for IBD Patients 1 year ago JohnIn BreakthroughsClinical Trials
Roche Unveils Breakthrough Sequencing by Expansion Technology That Could Transform Clinical Genomics 1 year ago JohnIn Biopharma HighlightsResearch Updates
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships 1 year ago JohnIn DealsInvestmentsLeadersPeople
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences 1 year ago JohnIn AI & DataIndustry ConferencesInnovationInvestmentsLeadersPeople
Clinical Trial Supply Europe 2025: AI, Supply Chain Resilience and Trial Operations Take Center Stage 1 year ago JohnIn Industry ConferencesLeadersPeople
FDA Greenlights Merilog—the First Insulin Aspart Biosimilar—Boosting Access and Competition in Diabetes Care 1 year ago JohnIn Breaking NewsClinical TrialsFDA Approvals
FDA Approves Vimseltinib (Romvimza) for Tenosynovial Giant Cell Tumor—A Targeted Therapy First 1 year ago JohnIn Biopharma HighlightsBreakthroughsFDA Approvals
FDA Clears Innovative SPN-830 Apomorphine Infusion System for Advanced Parkinson’s Disease 1 year ago JohnIn FDA ApprovalsInnovationTechnology
FDA Clears First-ever Pentavalent Meningococcal Vaccine—A New Era in Preventing Invasive Meningococcal Disease 1 year ago JohnIn DealsFDA ApprovalsPharma Industry Updates
UK Advances Clinical Trial Landscape: Historic Regulation Reform Paves Way for Efficiency and Inclusivity 1 year ago JohnIn BreakthroughsClinical Trials
Final Analysis of TROPION-Breast01 Reveals No Overall Survival Benefit for Dato-DXd in HR+/HER2– Breast Cancer, Despite PFS Gains 1 year ago JohnIn Research UpdatesTop Stories
India Poised to Become Major Hub for Early-Stage Clinical Trials Amid Global Shifts 1 year ago JohnIn Breaking NewsClinical Trials
Grace Therapeutics’ GTx-104 IV Nimodipine Formulation Reduces Hypotension and ICU Burden in Aneurysmal Subarachnoid Hemorrhage Phase III Trial 1 year ago JohnIn Biopharma HighlightsBreaking NewsTop Stories
